DH DEFINITIVE HEALTHCARE CORP

Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief Financial Officer, Casey Heller, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference.

The Definitive Healthcare presentation is scheduled for Tuesday, September 9, 2025, at 9:15 a.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the Definitive Healthcare investor relations website at . A replay of the webcast will also be available for a limited time.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Learn more at .

Investor Contact:

Brian Denyeau

ICR for Definitive Healthcare



646-277-1251

Media Contact:

Bethany Swackhamer



EN
02/09/2025

Underlying

DHDEFINITIVE HEALTHCARE CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEFINITIVE HEALTHCARE CORP

 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Glo...

Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief Financial Officer, Casey Heller, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference. The Definitive Healthcare presentation is scheduled for Tuesday, September 9, 2025, at 9:15 a.m. Eastern Time. A live webcast of the pre...

September 2, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Reports Financial Results for Second Quarter Fis...

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025 Second Quarter Revenue Exceeded Guidance FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025.  Second Quarter 2025 Financial Highlights: Revenue was $60.8 million, a decrease of 5% from $63.7 million in Q2 2024. Net Loss was $(9.3) million, or (15)% of revenue, compared to $(306.2) million in...

August 7, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Announces Timing of Its Second Quarter 2025 Fina...

Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the ev...

July 24, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeannine Lombardi, Definitive Healthcare’s new Chief Human Resource Officer, an inducement award consisting of 421...

July 1, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted an inducement award. The Committee granted Tina Hannagan, Definitive Healthcare’s Chief Commercial Officer, an inducement award consisting of 830,565 t...

June 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch